These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. The Evolution of the Safety of Plasma Products from Pathogen Transmission-A Continuing Narrative. Farrugia A Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839590 [TBL] [Abstract][Full Text] [Related]
18. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology. Keeling D; Tait C; Makris M Haemophilia; 2008 Jul; 14(4):671-84. PubMed ID: 18422612 [TBL] [Abstract][Full Text] [Related]
19. New high-technology products for the treatment of haemophilia. Pipe SW; Saint-Remy JM; Walsh CE Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373 [TBL] [Abstract][Full Text] [Related]
20. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain. Batlle J; Villar A; Liras A; Alonso C; Altisent C; Brito D; Moreno M; Lucía F; Sedano C; Prieto M; Calvente N; Aznar JA; Jiménez V; Soriano V; Martorell JR; Iruín G; Bergua JM; Aguilar C Blood Coagul Fibrinolysis; 2008 Jul; 19(5):333-40. PubMed ID: 18600079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]